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Disinfection of drinking water has led to a 
major improvement in public health since 
it was first applied in the 20th century. It 
has now been > 30 years since it was discov-
ered that by-products can be formed in small 
quantities as part of the chlorination process 
(Rook 1974). Chlorination disinfection by-
products (DBPs) are formed when water is 
chlorinated and organic matter in the water 
reacts with chlorine. Their formation and 
occurrence depends on many factors, includ-
ing the chlorine dose, type of treatment, pH, 
temperature, residence time, and bromine 
levels [International Programme on Chemical 
Safety (IPCS) 2000; Nieuwenhuijsen et al. 
2000a]; up to 600 DBPs have been identified 
(Richardson 1998; Richardson et al. 2008). 
Different mixtures of by-products may exist 
in different locations, depending on the vari-
ous factors mentioned above, making it more 
difficult to assess any health effects of DBPs, 
particularly in epidemiologic studies. 
Ingestion of water is thought to be the 
main route of exposure for nonvolatile DBPs 
such as halo  acetic acids (HAAs). Exposure to 
volatile DBPs such as trihalomethanes (THMs) 
may occur through inhalation and absorption 
during activities such as showering, bathing, 
and swimming (Nieuwenhuijsen et al. 2000a). 
Modeling of THM uptake has suggested that 
swimming may lead to the highest levels of 
THMs in the blood (Whitaker et al. 2003). 
Various reviews have been conducted on 
the epidemiology of chlorination by-products 
and reproductive outcomes. These have con-
cluded that there are still many problems to 
overcome and that the results are inconsistent 
and inconclusive, except perhaps for small-
for-gestational-age/intrauterine growth retar-
dation (Bove et al. 2002; Gevecker Graves 
et al. 2001; IPCS 2000; Nieuwenhuijsen et al. 
2000b; Reif et al. 1996; Tardiff et al. 2006). 
In addition, two meta-analyses by Hwang 
and Jaakkola (2003) and Hwang et al. (2008) 
reported evidence for an effect of exposure to 
chlorination by-products on the risk of neu-
ral tube defects, urinary system defects, and 
ventricular septal defects, but risks for other 
anomalies were considered hetero  geneous and 
inconclusive. However, the meta-analyses by 
Hwang and Jaakkola (2003) included only 
five studies and did not include more recent 
studies, and the study by Hwang et al. (2008) 
generally focused on a few sub  categories of 
anomalies and also did not include some 
recent studies. In this article we review the 
epidemiologic evidence and provide sum-
mary risk estimates of the association between 
chlorination disinfection by-products and 
congenital anomalies; we also provide recom-
mendations for future studies.
Methods
We searched PubMed (National Center for 
Biotechnology Information 2009) using the 
following key words: “chlorination,” “chlorina-
tion by-products,” “chlorination byproducts,” 
“trihalomethanes,” and “haloacetic acids.” 
We searched for these key words alone and 
in combination with the following key words 
for congenital anomalies: “birth defects,” 
“congenital anomalies,” “congenital malfor-
mations,” “urinary,” “respiratory,” “cardio-
vascular,” “neural tube defects” (NTDs), and 
“cleft lip/palate.” Furthermore, we searched 
in review and meta-analysis articles on the 
topic (Bove et al. 2002; Gevecker Graves et al. 
2001; Hwang and Jaakkola 2003; Hwang 
et al. 2008; IPCS 2000; Nieuwenhuijsen et al. 
2000b; Reif et al. 1996; Tardiff et al. 2006). 
We retrieved all epidemiologic studies exam-
ining the relation between chlorination by-
products and congenital anomalies. 
We included all epidemiologic studies 
that evaluated the relationship between some 
index of chlorination by-products (treatment, 
water source, DBP measurements, and both 
DBP measurements and personal character-
istics) and any congenital anomalies. We did 
not score the studies for quality, given the 
relatively small number of studies involved. 
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oBjectives: The aim of this study was to review epidemiologic evidence, provide summary risk 
estimates of the association between exposure to chlorination disinfection by-products (DBPs) and 
congenital anomalies, and provide recommendations for future studies.
da t a s o u r c e s a n d e x t r a c t i o n: We included all published epidemiologic studies that evaluated a 
relationship between an index of DBP exposure (treatment, water source, DBP meas  urements, and 
both DBP measurements and personal characteristics) and risk of congenital anomalies. When three 
or more studies examined the same exposure index and congenital anomaly, we conducted a meta-
analysis to obtain a summary risk estimate comparing the highest exposure group with the lowest 
exposure group. When five or more studies examined total trihalomethane (TTHM) exposure and a 
specific congenital anomaly, we conducted a meta-analysis to obtain exposure–response risk estimates 
per 10 µg/L TTHM. 
da t a synthesis: For all congenital anomalies combined, the meta-analysis gave a statistically sig-
nificant excess risk for high versus low exposure to water chlorination or TTHM [17%; 95% con-
fidence interval (CI), 3–34] based on a small number of studies. The meta-analysis also suggested a 
statistically significant excess risk for ventricular septal defects (58%; 95% CI, 21–107), but this was 
based on only three studies, and there was little evidence of an exposure–response relationship. We 
observed no statistically significant relationships in the other meta-analyses. We found little evidence 
for publication bias, except for urinary tract defects and cleft lip and palate. 
co n c l u s i o n: Although some individual studies have suggested an association between chlorination 
disinfection by-products and congenital anomalies, meta-analyses of all currently available studies 
demonstrate little evidence of such an association. 
key w o r d s : birth defects, congenital anomalies, disinfection by-products, fetal development, repro-
ductive health, trihalomethanes. Environ Health Perspect 117:1486–1493 (2009).  doi:10.1289/
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We obtained summary risk estimates for 
general water chlorination by conducting 
meta-analyses when three or more studies fea-
tured the same congenital anomalies. In these 
analyses we calculated risk estimates for high 
versus low exposure, using the exposure groups 
as defined in the original studies [e.g., high vs. 
low total trihalo  methane (TTHM)] concentra-
tion, chlorination vs. non  chlorination, or chlo-
rination vs. chloramina  tion]. When three or 
more studies had measurements of individual 
THMs or brominated fractions, we conducted 
meta-analyses, again comparing the highest 
versus the lowest exposure groups of the origi-
nal studies. We tested for hetero  geneity in risk 
estimates using the Q test (Cochran 1954). 
When the result of the Q test was statistically 
significant (p < 0.05), implying hetero  geneity 
between the studies, we used random effects 
analyses, using the method of DerSimonian 
and Laird (1986). When the Q test was not 
statistically significant, we used fixed effects 
analyses, using the Mantel-Haenszel method 
(Mantel and Haenszel 1959). The summary 
estimates were weighted by the inverse variance 
of each study, taking into account whether a 
fixed or random effects model was used. We 
used STATA statistical software (StataCorp, 
College Station, TX, USA). 
Where five or more studies, each with 
the same outcome and exposure classification 
(applicable only to TTHM) were split into 
three or more exposure categories, we con-
ducted a meta-analysis to obtain exposure–
response risk estimates per 10 mg/L TTHM. 
All the included studies provided data on 
exposure in a categorical way. The midpoint 
of each given exposure category was used in 
the estimation of exposure–response slopes 
for each of the studies. If the highest expo-
sure category was open-ended (i.e., greater 
than some concentration), a value of half the 
width of the previous exposure category was 
added to the cut point of highest exposure 
category, using the method described by Key 
et al. (2006). In the absence of data to the con-
trary, we assumed that the natural logarithm 
of the measure of effect varied linearly with 
concentration of TTHM in drinking water. 
Exposure–response slopes for those exposed 
to TTHM in drinking water were calculated 
using linear regression of log-transformed risk 
estimates. We performed the meta-analyses 
using R software (R Project for Statistical 
Computing 2009) and scripts adapted from 
those of Key et al. (2006). A random effects 
model was used for the meta-analysis of expo-
sure–response slopes of individual studies. 
Regression slopes of exposure–response slopes 
derived from individual studies were plotted 
together with the summary slope produced 
from their meta-analysis. 
We also produced forest and funnel plots 
(Light and Pillemer 1984). Forest plots show 
the odds ratio (OR) with its confidence inter-
val (CI) for each study included in the meta-
analyses and the estimation of the summary 
OR. The sizes of the square markers of OR 
in the plot represent the relative weight each 
study contributed to the regression. 
Funnel plots show, for every study, the 
effect estimate (OR and relative risk) of the 
study against some precision meas  ure (SE in 
this case) to examine possible bias due to pub-
lication. We also conducted a weighted Egger 
test, a linear regression in which the response 
is the estimated effect and the explanatory 
variable is a precision term (1/SE). A large 
deviation from zero of the slope term suggests 
publication bias (Egger et al. 1997). 
Results
The extracted and evaluated studies are shown 
in Table 1. A third of these studies were con-
ducted in the United States (Aschengrau 
et al. 1993; Bove et al. 1995; Klotz and 
Pyrch 1999; Luben et al. 2008; Shaw et al. 
2003), followed by Sweden (Cedergren et al. 
2002; Källen and Robert 2000), England 
and Wales (Iszatt N, Nieuwenhuijsen MJ, 
Toledano MB, Nelson P, Elliott P, unpub-
lished data; Nieuwenhuijsen et al. 2008), 
Canada (Dodds et al. 1999; Dodds and King 
2001), Norway (Hwang et al. 2002; Magnus 
et al. 1999), Australia (Chisholm et al. 2008), 
and Taiwan (Hwang et al. 2008). Five were 
case–control studies [Aschengrau et al. 1993; 
Iszatt N, Nieuwenhuijsen MJ, Toledano MB, 
Nelson P, Elliott P, unpublished data; Klotz 
and Pyrch 1999; Luben et al. 2008; Shaw et al. 
2003 (includes two studies)], whereas the rest 
were cross-sectional, population-based studies, 
generally using registry data, which limited the 
opportunity to adjust for potential confound-
ers. Most included live births, fetal deaths, and 
terminations. A number of the studies used 
only treatment method (chlorination vs. non-
chlorination, chlorination vs. chloramination) 
as the index of exposure (Aschengrau et al. 
1993; Hwang et al. 2002; Källen and Robert 
2000; Magnus et al. 1999), whereas the other 
studies used a meas  ure of DBP exposure level, 
mostly THMs (Bove et al. 1995; Cedergren 
et al. 2002; Chisholm et al. 2008; Dodds 
et al. 1999; Dodds and King 2001; Iszatt N, 
Nieuwenhuijsen MJ, Toledano MB, Nelson 
P, Elliott P, unpublished data; Klotz and Pyrch 
1999; Luben et al. 2008; Nieuwenhuijsen et al. 
2008; Shaw et al. 2003). Generally, studies 
used TTHM levels, but some studies also eval-
uated individual THMs or the brominated 
fraction (Dodds and King 2001; Iszatt N, 
Nieuwenhuijsen MJ, Toledano MB, Nelson 
P, Elliott P, unpublished data; Nieuwenhuijsen 
et al. 2008; Shaw et al. 2003). The levels of 
brominated THM were high in Australia and 
made up most of the TTHM there (Chisholm 
et al. 2008). Klotz and Pyrch (1999) also had 
a meas  ure of halo  aceto  nitrile (HAN) and 
HAA exposure, and Luben et al. (2008) a 
measure of HAA exposure. Levels of DBPs in 
Scandinavia (Cedergren et al. 2002; Hwang 
et al. 2002; Källen and Robert 2000; Kuivinen 
and Johnsson 1999; Magnus et al. 1999) and 
Taiwan (Hwang et al. 2008) tended to be lower 
than in the other countries, with median levels 
around 10 µg/L TTHM, with approximately 
20% > 20 µg/L. The Canadian (Dodds et al. 
1999; Dodds and King 2001) and Australian 
(Chisholm et al. 2008) studies examined the 
highest TTHM levels (> 100 µg/L). Three 
studies examined personal behavioral activi-
ties such as ingestion, showering, and bathing 
(Iszatt N, Nieuwenhuijsen MJ, Toledano MB, 
Nelson P, Elliott P, unpublished data; 
Klotz and Pyrch 1999; Luben et al. 2008). 
The largest study was conducted in England 
and Wales and included > 2.5 million births 
and > 20,000 cases of congenital anomalies 
(Nieuwenhuijsen et al. 2008). Dodds et al. 
(1999) and Dodds and King (2001) used 
the same subjects but examined the effect of 
TTHM and individual THMs, respectively. 
The study by Hwang et al. (2002) included 
3 years of subjects from Magnus at al. (1999), 
and therefore only the former was included in 
any of the meta-analyses. The report by Shaw 
et al. (2003) contained two case–control stud-
ies (study 1 and study 2), and they have been 
treated as separate studies. 
A number of studies found statistically 
signifi  cant positive associations between water 
chlorination (THM levels or chlorinated water) 
and any congenital anomaly (Bove et al. 1995; 
Chisholm et al. 2008; Hwang et al. 2002), 
whereas others did not (Aschengrau et al. 
1993; Hwang et al. 2008; Magnus et al. 1999). 
There was evidence of heterogeneity between 
studies (p = 0.041). The meta-analysis, using 
a random effects model, produced a statisti-
cally significant summary effect measure of 
17% excess risk (95% CI, 2–34) [(Table 2, 
Figure 1; see also Supplemental Material 1, 
Table 1, available online (doi:10.1289/ehp. 
0900677.S1 via http://dx.doi.org/)]. 
Neural tube defects were one of the most 
commonly studied groups of congenital anom-
alies, and three studies found statistically sig-
nificant positive associations between THM 
levels or chlorinated water and neural tube 
defects (Bove et al. 1995; Dodds and King 
2001; Klotz and Pyrch 1999), whereas others 
did not (Chisholm et al. 2008; Dodds et al. 
1999; Hwang et al. 2002; Källen and Robert 
2000; Magnus et al. 1999; Nieuwenhuijsen 
et al. 2008; Shaw et al. 2003) [Table 2; see 
also Supplemental Material 1, Tables 2a–2d 
(doi:10.1289/ehp.0900677.S1)]. There 
appeared to be little difference between the 
findings of using TTHM levels or bromi-
nated species as the exposure index. The meta- 
analyses for high versus low exposure for water Nieuwenhuijsen et al.
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chlorination (THM levels or chlorinated water) 
and bromo  dichloro  methane (BDCM) showed 
some excess of risk, but it was not statistically 
significant. We found no evidence for an expo-
sure–response relation  ship with TTHM levels 
(OR = 1.00; 95% CI, 0.94–1.07 per 10 µg/L 
TTHM) [see Supplemental Material 3, 
Figures 1–3 (doi:10.1289/ehp.0900677.S1)]. 
Klotz and Pyrch (1999) found a statistically 
significant association between TTHM levels 
in the water and neural tube defects, but not 
with levels of halo  acetonitriles and halo  acetates. 
Inclusion of personal behavioral activities made 
little difference in the results. In addition, the 
effects were most pronounced in offspring 
from women who did not take supplemen-
tary vitamins, but these findings were not con-
firmed by Shaw et al. (2003). Findings of the 
Table 1. Summary of epidemiologic studies on chlorinated disinfection by-products and adverse reproductive outcomes.
Reference Study details Cases Sample population Exposure assessment Other risk factors included
Aschengrau  
et al. 1993
Massachusetts, USA 
Two hospitals 1977–1980  
1,039 major congenital 
malformations, 
urinary tract defects, 
respiratory tract defects; 
1,177 controls
1,039 major congenital anomalies, urinary 
tract defects, respiratory tract defects 
Ongoing 
population-based 
study of 14,130 
obstetrics patients
Based on maternal residential 
address to ascertain type of 
water supply, chlorination vs. 
chloramination, and ground/
mixed water vs. surface water
Maternal age, pregnancy 
history, alcohol, ethnicity, 
hospital payment, other water 
contaminants
Bove et al. 1995 New Jersey, USA  
75 towns with a public 
water supply 1985–1988 
Sample population: 81,602
All birth defects, 669 surveillance; 
118 central nervous system defects; 
83 oral cleft defects; 56 NTDs; 108 major 
cardiac defects 
From live birth and 
fetal death (> 20 
weeks) registries
Based on maternal residential 
address and municipal water 
surveys to estimate monthly 
THM levels (five or six  
exposure categories)
Maternal age, ethnicity, sex 
of baby, primipara, pre  natal 
care, education, previous 
stillbirth or miscarriage, other 
contaminants
Dodds et al. 
1999
Nova Scotia, Canada 
1988–1995 study  
population: 49,842 births
77 NTDs, 82 cleft defects,  
430 major cardiac defects, 197 stillbirths, 
96 chromosomal abnormalities
Live and still birth 
registry and fetal 
anomaly database
Based on maternal residential 
address and TTHM levels for 
public water facilities (three 
sampling locations) modeled 
using linear regression on 
the basis of observations by 
year, month, and facility (four 
exposure categories)
Maternal age, parity, maternal 
smoking, attendance prenatal 
classes, neighborhood, family 
income, sex of baby, pregnancy 
and predelivery weight 
Adjusted: NTDs, cardiac 
defects, chromosomal 
abnormalities, income
Dodds and King 
2001
Nova Scotia, Canada 
1988–1995  
Study population:  
49,842 births
77 NTDs,  
430 cardiovascular anomalies,  
85 cleft defects, 96 chromosomal 
abnormalities
Live and still birth 
registry and fetal 
anomaly database
Based on maternal residential 
address and TTHM, chloroform, 
and BDCM levels for public 
water facilities (three sampling 
locations) modeled using linear 
regression on the basis of 
observations by year, month, and 
facility (four exposure categories) 
(r = 0.44 for TTHM and BDCM)
Maternal age, parity, maternal 
smoking, attendance prenatal 
classes, neighborhood, family 
income, sex, pregnancy and 
predelivery weight  
Adjusted: NTDs, cardiac defects, 
cardiovascular; chromosomal; 
maternal age and income; 
Cleft: maternal age
Klotz and Pyrch 
1999
New Jersey, USA 
1993–1994 
Sample population: all 
births, of which 112 cases 
and 248 controls were 
selected
112 NTDs  Birth registry 
and birth defects 
and fetal death 
(> 20 weeks) 
registry
Based on residential address 
and public water facility TTHM 
data, and tap-water sampling 
for TTHM, HANs, and HAAs 
(three to five exposure  
categories)
Sociodemographics: pregnancy 
and premedical history, 
parental occupation, use of 
vitamins
Magnus et al. 
1999
Norway Study population: 
141,077
2,608 all birth defects, 62 NTDs, 250 major 
cardiac defects, 91 respiratory defects, 
122 urinary defects
Birth registry 
(≥ 16 weeks)
Chlorination yes vs. no  
Color high vs. low (in  
chlorinated water average 
TTHM = 9.4 µg/L , average 
HAAs = 14.6 µg/L)
Maternal age, parity,  
geographical placement,  
population density, industry 
profile
Källen and 
Robert 2000
Sweden (1985–1994) 
Sample population: 
no chlorination
74,324 singletons 
Na-hypochlorite: 
27,731 singletons  
chlorine dioxide: 
15,429 singletons
Congenital anomalies, including 
NTDs: 7 anencephaly, 61 spina bifida, 
35 hydrocephaly, 1,108 cardiac defects, 
223 facial cleft defects, 213 hypospadias
Birth registry, 
congenital 
malformation 
registry, child 
cardiology 
registry, and 
cytogenetic 
registry
No vs. sodium hypochlorite (no 
vs. chlorine dioxide)
Year of birth, maternal age, 
parity, maternal education, 
maternal smoking, congenital 
malformation, and childhood 
cancer, maternal age, year  
of birth 
Cedergren et al. 
2002
Sweden 1982–1996  
Study population: 59,422
753 cardiac defects Birth registry > 10 mg/L vs. ≤ 10 mg/L TTHM 
in surface water; hypochloride 
and chlorine dioxide vs. 
hypochloride in surface water
Maternal age, parity, smoking, 
education
Hwang et al. 
2002
Norway 1993–1998 
Sample population: 
285,631
5,764 any birth defect, 138 NTDs, 
46 anencephalus, 81 spina bifida, 
68 hydrocephalus, 537 cardiac defects, 
279 ventricular septal defects, 73 atrial 
septal defects, 192 respiratory defects, 
343 oral cleft defects, 95 cleft palate, 
67 cleft lip, 232 urinary tract defects, 
102 obstructive urinary tract defects
Birth registry 
(> 16 weeks)
Chlorination (yes/no) and level 
of water color (mg Pt/L: > 10, 
10–19.9, ≥ 20)
Maternal age, parity, 
socioeconomic status, 
centrality, population density
Continued, next pageChlorination and congenital anomalies
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sub  categories of neural tube defects including 
anencephalus, spina bifida, and hydro  cephalus 
were also mixed, and none of the studies found 
a statistically significant association except for 
Shaw et al. (2003) who found a statistically sig-
nificant reduced risk. The meta-analyses showed 
some excess of risk for anencephalus and spina 
bifida, but it was not statistically significant. 
Cedergren et al. (2002), Chisholm et al. 
(2008), and Hwang et al. (2002) found statis-
tically significant positive associations between 
chlorinated water with a higher color content, 
levels of TTHM > 10 µg/L, and high levels of 
DBPs (≥ 130 µg/L), respectively, and cardio-
vascular congenital anomalies, but other stud-
ies did not observe such an association (Bove 
et al. 1995; Dodds et al. 1999; Dodds and 
King 2001; Källen and Robert 2000; Magnus 
Table 1. Continued
Reference Study details Cases Sample population Exposure assessment Other risk factors included
Shaw et al. 2003 California, USA 
Study 1: 538 NTD cases 
and 539 controls selected 
Study 1: 538 NTDs  
(anencephaly and spina bifida)
Live births, fetal 
deaths, and 
terminations
Studies 1 and 2: continuous 
TTHM categorical: 0, 1–24, 
25–49, 50–74, and ≥ 75 µg/L 
TTHM
Ethnicity, education, body 
mass index, use of vitamins
California, USA 
Study 2: 265 NTD cases, 
207 conotruncal heart 
defect cases, 109 orofacial 
cleft cases, 481 controls
Study 2: 265 NTDs  
(anencephaly and spina bifida),  
207 conotruncal heart defects,  
481 orofacial clefts
Also Study 1: ≥ 50 vs. < 50 µg/L 
and > 5 glasses ≥ 50 vs. 
< 50 µg/L and > 5 glasses 
Study 1: chloroform ≥ 13.2 
vs. < 12.2 µg/L BDCM ≥ 4.2 
vs. < 4.2 µg/L CDBM ≥ 1.7 vs. 
< 1.7 µg/L 
Study 2: chloroform ≥ 15.0 
vs. < 15.0 µg/L BDCM ≥ 9.6 
vs. < 9.6 µg/L CDBM ≥ 3.6 vs. 
< 3.6 µg/L MTHFR genotype
Nieuwenhuijsen 
et al. 2008
England and Wales 
2,605,226
Congenital anomalies, 1,434 respiratory 
(ICD-10 codes Q30–Q34), 8,809 major 
cardiac (Q20–Q28), 5315 urinary (Q60–Q64), 
2,267 abdominal wall (Q79), 3,334 NTDs 
(Q00, Q01, and Q05), 3,736 cleft lip and 
palate (Q35–Q37)
Birth and  
stillbirth  
registries and 
national and 
local congenital 
anomalies 
registries
THMs Maternal age, deprivation, sex 
Chisholm et al. 
2008
Perth, Australia 2000–2004 
20,870 live births 
1,097 congenital anomalies, 59 nervous 
system defects (BPA 74,000–74,299), 260 
cardiovascular defects (BPA 74,500–74,299), 
17 respiratory system defects (BPA  
74,800–74,899), 101 gastrointestinal 
defects (BPA 74,900–75,199), 351 uro  genital 
defects (BPA 75,200–75,399), 282 musculo-
skeletal defects (BPA 75,400–75,699), 36 
congenital anomalies of integument (BPA 
75,700–75,799) (n = 1,097)
Western  TTH  Maternal age 
Luben et al. 2008  Arkansas, USA  
1998–2002 
320 cases and 614 
controls, and a subset of 
40 cases and 243 controls
320 and 40 hypospadias Birth and birth 
defect registry 
from Arkansas 
Reproductive 
Health Monitoring 
System and 
National Birth 
Defects  
Prevention Study
THMs and HAAs, and personal 
characteristics in the subset 
Maternal and paternal age, 
race, and education, marital 
status, maternal use of alcohol 
and tobacco, parity, prenatal 
care, 1- and 5-min Apgar 
scores, birth weight, method of 
delivery, any risks, procedures, 
or complications associated 
with delivery
Hwang et al. 
2008 
Taiwan 2001–2003 
396,049 births 
2,148 congenital anomalies, including 
43 anencephalus (ICD-9 code 740.0), 
118 hydrocephalus (code 741.0), 59 
ventricular septal defects (code 745.4), 
19 atrial septal defects (code 745.5), 
24 tetralogy of Fallot (code 745.2), 
358 cleft palate or lips (code 749.0), 
cleft lip (code 749.1), 76 renal agenesis 
and dysgenesis (code 753.0), 49 
obstructive urinary tract defects (code 
753.2), 72 hypospadias (code 752.61), 
166 chromosome anomalies (code 758)
Birth registry High (TTHM 20 + µg/L), 
medium (TTHM 10–19 µg/L), 
low exposure (TTHM 5–9 
µg/L), and 0–4 µg/L
Sex of infant, maternal age 
(< 20 years; 20–34 years; 
≥ 35 years), plurality (singleton 
and multiple birth), maternal 
health status, population 
density
Iszatt N, 
Nieuwenhuijsen 
MJ, Toledano 
MB, Nelson 
P, Elliott P, 
unpublished data
Southeast England 
1997–1998  
363 hypo  spadias cases and 
346 population controls
363 hypospadias Population based THMs Income, birth weight, folate 
supplement use during 
pregnancy, maternal smoking, 
maternal occupational 
exposure to phthalates
Abbreviations: BPA, British Paediatric Association Classification of Disease (BPA 1979); CDBM, chlorodibromomethane; ICD-9, International Classification of Diseases, 9th Revision 
[World Health Organization (WHO) 1977]; ICD-10, International Classification of Diseases, 10th Revision (WHO 1992). Nieuwenhuijsen et al.
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et al. 1999; Nieuwenhuijsen et al. 2008; 
Shaw et al. 2003) [Table 2; see Supplemental 
Material 1, Tables 3a–3c (doi:10.1289/
ehp.0900677.S1)]. There was some evidence 
for hetero  geneity in study results (p = 0.017). 
The random effects estimate of the meta-
analysis for all major cardiac defects com-
bined showed a nonstatistically significant 
16% excess risk. There was no evidence of an 
exposure–response relationship (OR = 1.01; 
95% CI, 0.95–1.08 per 10 µg/L TTHM) 
[see Supplemental Material 3, Figures 1–3 
(doi:10.1289/ehp.0900677.S1)]. Furthermore, 
the brominated species did not show statis-
tically significant associations. However, in 
a very large study, Nieuwenhuijsen et al. 
(2008) found a statistically significant asso-
ciation between bromo  form levels and a sub-
set of isolated major cardio  vascular defects 
[2 to < 4 vs. < 2 µg/L bromoform, OR = 1.13 
(95% CI, 0.99–1.29); ≥ 4 vs. < 2 µg/L bro-
moform, OR = 1.18 (95% CI, 1.00–1.39)]. 
Furthermore, ventricular septal defects showed 
an increased risk for high versus low exposure 
in all three studies examining these defects 
(Hwang et al. 2002, 2008; Nieuwenhuijsen 
et al. 2008), and a statistically significant 
excess risk was observed in the meta-analysis 
(OR = 1.59; 95% CI, 1.21–2.07) (Figure 2). 
However, only Hwang et al. (2002) showed 
some indication of an exposure–response 
relation  ship. Ventricular septal defects showed 
little association with brominated THM levels 
in the study by Nieuwenhuijsen et al. (2008). 
No statistically significant associations were 
observed with atrial septal defects in the two 
studies by Hwang et al. (2002, 2008). 
Two studies found a statistically sig-
nificant positive association between chlori-
nated water and congenital anomalies of the 
respiratory system (Aschengrau et al. 1993; 
Hwang et al. 2002), but two other studies 
using TTHM levels did not (Chisholm et al. 
2008; Nieuwenhuijsen et al. 2008) [Table 2; 
see also Supplemental Material 1, Table 4 
(doi:10.1289/ehp.0900677.S1)]. Results of 
the two Swedish studies were inconsistent 
(Hwang et al. 2002; Magnus et al. 1999). The 
meta-analysis showed some excess of risk, but 
it was not statistically significant. 
Studies on oral cleft or/and cleft palate 
have generally shown no statistically sig-
nificant associations with chlorinated water, 
TTHM, and brominated THMs, except for 
the study by Bove et al. (1995) [Table 2; see 
also Supplemental Material 1, Tables 5a,5b 
(doi:10.1289/ehp.0900677.S1)]. The meta-
analyses showed no evidence for an asso-
ciation. In addition, the exposure–response 
relationship was not statistically significant 
(OR = 1.02; 95% CI, 0.97–1.06 per 10 µg/L 
TTHM) [see Supplemental Material 3, 
Figures 1–3 (doi:10.1289/ehp.0900677.S1)].
Two studies reported statistically sig-
nificant associations between chlorinated 
water or TTHM levels and urinary system 
defects (Aschengrau et al. 1993; Magnus et al. 
1999), whereas one did not (Nieuwenhuijsen 
et al. 2008) [Table 2; see also Supplemental 
Material 1, Tables 6a,6b (doi:10.1289/
ehp.0900677.S1)]. Chisholm et al. (2008) 
reported almost statistically significant effects 
(OR = 1.40; 95% CI, 0.98–1.99), as did 
Hwang et al. 2002 (OR = 1.46; 95% CI, 
1.00–2.13), and there was evidence for 
hetero  geneity (p = 0.012) in study results. 
Nieuwenhuijsen et al. (2008) did not show 
an association with brominated THM species 
and found no statistically significant associa-
tions for obstructive urinary defects, although 
Hwang et al. (2002, 2008) did find excess 
risk. The meta-analyses showed some excess of 
risk, but it was not statistically significant. 
Two studies examined the association 
between abdominal wall defects and chlori-
nated water or THM levels and did not find 
an association (Källen and Robert 2000; 
Nieuwenhuijsen et al. 2008) [see Supplemental 
Material 1, Table 7 (doi:10.1289/ehp. 
0900677.  S1)]. However, Nieuwenhuijsen 
et al. (2008) found a statistically significant 
association between isolated gastroschisis and 
bromoform levels [2–4 vs. < 2 µg/L bromo-
form, OR = 1.11 (95% CI, 0.85–1.45); ≥ 4 
vs. < 2 µg/L bromoform, OR = 1.38 (95% CI, 
1.00–1.92)].
The studies on hypospadias generally 
showed no statistically significant associations 
between chlorinated water or TTHM levels, 
and neither did the meta-analysis [Table 2; 
see also Supplemental Material 1, Table 8 
(doi:10.1289/ehp.0900677.S1)]. However, 
Iszatt et al. (Iszatt N, Nieuwenhuijsen MJ, 
Toledano MB, Nelson P, Elliott P, unpub-
lished data) reported a statistically significant 
excess risk between BDCM ingestion estimates 
and hypo  spadias (1st vs. 4th quartile BDCM, 
OR = 1.69; 95% CI, 1.04–2.73). Similarly, 
Luben et al. (2008) reported that risk of hypo-
spadias was associated with moderate inges-
tion of > 0–32.5 µg/day TTHM. Luben et al. 
(2008) did not show a statistically significant 
association between HAA exposure levels and 
hypo  spadias but showed excess risk for TTHM 
uptake, which takes into account various per-
sonal behaviors and exposure routes, although 
this was not statistically significant. Iszatt et al. 
(Iszatt N, Nieuwenhuijsen MJ, Toledano MB, 
Nelson P, Elliott P, unpublished data) did not 
find such an association in a much larger study. 
Table 2. Summary of meta-analyses of epidemiological studies on chlorinated disinfection by-products and adverse reproductive outcomes.
Outcome Exposure
Studies 
included 
p-Value of test for 
heterogeneity
Egger test; weighted 
p-value for intercept
Summary  
estimate
Any congenital anomaly High vs. low chlorination by-products a,b,i,l,n  0.041 0.16 1.17 (1.02–1.34)
Nervous system defects including neural tube defects High vs. low chlorination by-products b,c,e,i,j,k,l,m 0.058 0.11 1.06 (0.89–1.26)
Nervous system defects including neural tube defects Per 10 µg/L TTHM b,c,e,j,k,l,m 0.46 0.20 1.01 (0.95–1.06)
Nervous system defects including neural tube defects BDCM d,j,k 0.005 0.12 1.15 (0.59–2.25)
Anencephalus High vs. low chlorination by-products i,j,k,o  0.45 0.17 1.48 (0.92–2.39)
Hydrocephalus High vs. low chlorination by-products g,i,o  0.18 0.54 0.92 (0.57–1.48)
Spina bifida High vs. low chlorination by-products g,i,j,k,l  0.35 0.55 1.22 (0.76–1.97)
Major cardiac defects High vs. low chlorination by-products b,c,g,h,i,k,l,m 0.017 0.27 1.16 (0.98–1.37)
Major cardiac defects Per 10 µg/L TTHM b,c,k,l,m 0.49 0.39 0.99 (0.95–1.04)
Ventricular septal defects High vs. low chlorination by-products i,l,o 0.69 0.13 1.59 (1.21–2.07)
Respiratory defects High vs. low chlorination by-products a,i,l,m 0.064 0.29 1.12 (0.91–1.37)
Oral cleft or cleft palate defects High vs. low chlorination by-products a,b,c,g,i,k,l,o 0.32 0.067 0.98 (0.88–1.08)
Oral cleft or cleft palate defects Per 10 µg/L TTHM b,c,k,l,o 0.44 0.26 1.00 (0.96–1.05)
Cleft palate only High vs. low chlorination by-products i,k,l,o 0.26 0.53 1.03 (0.89–1.19)
Urinary tract defects High vs. low chlorination by-products a,i,l,m 0.012 0.002 1.33 (0.92–1.92)
Obstructive urinary defects High vs. low chlorination by-products i,l,o 0.37 0.12 1.07 (0.87–1.30)
Hypospadias High vs. low chlorination by-products g,n,o,p 0.20 0.17 1.03 (0.84–1.28)
Summary estimates are shown as OR (95%CI).
aAschengrau et al. (1993). bBove et al. (1995). cDodds et al. (1999). dDodds and King (2001). eKlotz and Pyrch (1999). fMagnus et al. (1999). gKällen and Robert (2000). hCedergren et al. 
(2002). iHwang et al. (2002). jStudy 1, Shaw et al. (2003). kStudy 2, Shaw et al. (2003). lNieuwenhuijsen et al. (2008). mChisholm et al. (2008). nLuben et al. (2008). oHwang et al. (2008). 
pIszatt N, Nieuwenhuijsen MJ, Toledano MB, Nelson P, Elliott P (unpublished data).Chlorination and congenital anomalies
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Generally there was little evidence for 
publication bias, except for cleft lip and pal-
ate, specifically when comparing the expo-
sure–response relationships (p = 0.04), and 
urinary tract defect (p = 0.002) [Table 2; see 
also Supplemental Material 2, Figures 1–15 
(doi:10.1289/ehp.0900677.S1)]. However, 
it should be noted that publication bias tests 
and funnel plots are not considered rigorous 
tests when the number of studies is small.
Discussion
The epidemiologic studies we reviewed showed 
inconsistent results for an association between 
drinking water chlorination by-products and 
risk of all congenital anomalies combined and 
of specific groups of anomalies. For all con-
genital anomalies combined, the meta-analysis 
gave a statistically significant excess risk for 
high versus low exposure to water chlorination 
or TTHM (17%; 95% CI, 3–34), based on 
a small number of studies. The meta-analysis 
also suggested a statistically significant excess 
risk for ventricular septal defects (58%; 95% 
CI, 21–107), but this was based on only three 
studies, and there was little evidence of an 
exposure–response relationship. We observed 
no statistically significant relationships in the 
other meta-analyses. We found little evidence 
for publication bias except for urinary tract 
defects and cleft lip and palate. 
Major limiting factors in studies on chlo-
rination by-products and congenital anoma-
lies are crude exposure assessment (with the 
exception of more recent studies), small 
samples sizes, heterogeneity in outcomes, 
and, to a lesser extent, potential for bias and 
confounding and ability to detect susceptible 
groups. These factors together may explain 
some of the mixed results and possibly the 
lack of associations. Furthermore, combined 
with the small number of studies included in 
the meta-analyses, these factors also reduce 
the strength of any conclusions that can be 
drawn from meta-analyses. These analyses are 
therefore not meant to provide final conclu-
sions on the subject, but instead evaluate the 
current status of this growing body of research 
and offer guidance for the way forward. 
Use of ecologic water supply zone esti-
mates as an exposure index may result in expo-
sure misclassification (Whitaker et al. 2003). 
Furthermore, ingestion has generally served as 
the primary exposure route of interest, in spite 
of the fact that uptake through showering, 
bathing, and swimming could be consider-
able, specifically for THMs; such exposure 
has been considered in only a few studies (e.g., 
Iszatt N, Nieuwenhuijsen MJ, Toledano MB, 
Nelson P, Elliott P, unpublished data; 
Klotz and Pyrch 1999; Luben et al. 2008). 
Combining information on individual water 
use with water zone estimates could provide 
better exposure estimates, but the individual 
information should be evaluated for measure-
ment error, because within-subject variabil-
ity in questionnaire data may be substantial 
(Forssén et al. 2008) and attenuate risk esti-
mates. Furthermore, exposure estimates have 
been based primarily on maternal residence 
at birth. This ignores any exposure that occurs 
outside the home (e.g., in the workplace) and 
also ignores the possibility that a mother has 
moved to another residence during her preg-
nancy. Therefore, exposure assessment based 
on maternal residence at birth may result in 
exposure misclassification. In addition, stud-
ies from Scandinavia (Cedergren et al. 2002; 
Hwang et al. 2002; Källen and Robert 2000; 
Magnus et al. 1999) and Taiwan (Hwang 
et al. 2008), for example, have generally shown 
low levels of DBPs with a small range, mak-
ing risk estimation more difficult because of 
a higher probability of exposure misclassifica-
tion, particularly where seasonal variability has 
not been taken into account. On the whole, 
epidemiologic studies have used THMs as a 
proxy for total DBP load, but THMs are not 
necessarily a good proxy meas  ure. Only two 
studies have investigated other DBPs such as 
HAAs (Klotz and Pyrch 1999; Luben et al. 
2008). The metabolism of different DBP spe-
cies varies (IPCC 2000), so it is insufficient to 
analyze DBPs as a whole or to use TTHM as 
a proxy. Investigation of the relation between 
non-THM by-products and reproductive 
outcomes is required to understand whether 
any specific DBP may cause health effects. 
A detailed assessment of the DBP mixture is 
required to provide an understanding of any 
observed results. 
Sample sizes have often been insufficient 
to produce stable results, and this may have 
resulted in chance findings and mixed results, 
although there are exceptions. For example, 
the studies by Hwang et al. (2002, 2008) and 
Nieuwenhuijsen et al. (2008) have provided 
sufficiently large numbers of cases to create var-
ious exposure categories with more stable risk 
estimates, and were able to examine exposure–
response relationships to some extent. A related 
limitation of the presented meta-analyses is the 
relatively small number of studies and therefore 
the need to conduct relatively simple analy-
ses, comparing high- versus low-exposure cat-
egories and combining what could be regarded 
as different and/or inconsistent estimates of 
exposure (e.g., high vs. low TTHM concentra-
tion and chlorination vs. nonchlorination). For 
instance, in Table 2, for all congenital anoma-
lies Chisholm et al. (2008) used cut points of 
< 60 µg/L TTHM for low exposure, whereas 
the high-exposure group used by Hwang et al. 
(2008) was > 20 µg/L TTHM. Although we 
assume that the meta-analysis is statistically 
accurate, the biological basis for comparing 
studies with this degree of heterogeneity in the 
definition of exposure is more problematic, 
and this should be taken into account when 
interpreting the results. Ideally, all the expo-
sure categories have the same cut  offs, but in 
practice, this is often impossible because of the 
different local conditions. We also performed 
sensitivity analyses leaving out the studies 
with qualitative estimates (e.g., chlorination 
Figure 1. Study and summary risk estimates for any congenital anomalies and 
chlorination by-products. Test for heterogeneity: Q = 9.944 on four degrees of 
freedom (p = 0.041). Egger test: weighted p-value for intercept 0.16.
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Figure 2. Study and summary risk estimates for ventricular septal defects and 
chlorination by-products. Test for heterogeneity: Q = 0.732 on two degrees of 
freedom (p = 0.69). Egger test: weighted p-value for intercept 0.13.
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vs. non  chlorination), but it generally did not 
materially change the summary risk estimates, 
except for nervous system defects including 
NTDs [from 1.06 (95% CI, 0.89–1.26) to 
1.28 (95% CI, 0.89–1.83)] and cleft palate 
only [from 1.03 (95% CI, 0.89–1.19) to 1.14 
(95% CI, 0.80–1.62)], but they remained not 
statistically significant. 
The analyses of TTHM exposure–response 
relationships combined more comparable 
exposure levels and were therefore probably 
more informative, but they could only be con-
ducted for a few end points because of the lack 
of a sufficient number of studies. The question 
here is whether TTHM may be the putative 
agent or a (not so good) marker for something 
else. Also, as a result of the small number of 
cases in the studies and to increase power, 
congenital anomalies have often been catego-
rized into main groups such as NTDs, major 
heart defects, and abdominal defects, or as all 
congenital anomalies combined. These anom-
alies, however, are generally hetero  geneous 
with respect to both pheno  type and presumed 
etiology, and combining them may not be 
appropriate. For example, Nieuwenhuijsen 
et al. (2008) showed that focusing on isolated 
sub  categories may result in different findings. 
Of course, this was possible only because of 
the large number of subjects in the study. 
The retrospective and registry-based nature 
of many of the studies has meant that informa-
tion on lifestyle factors, such as maternal smok-
ing and alcohol consumption, has often been 
lacking. These factors are not necessarily poten-
tial confounders, as it seems unlikely that levels 
of chlorination by-products are related to such 
factors, nor are they established risk factors for 
all congenital anomalies. However, behavioral 
patterns such as ingestion of tap water may 
be associated with these factors (Forssén et al. 
2007, 2008). Furthermore, registry complete-
ness is a factor that may make studies incom-
parable. In some places, case ascertainment 
occurs immediately after birth, so some mal-
formations may not be recorded, especially 
malformations such as hypo  spadias and cardiac 
defects, where the less-severe forms may not 
immediately be recognized. In Norway and 
Taiwan, birth defects reported up to 7 days 
after birth were included in the study (Hwang 
et al. 2008; Magnus et al. 1999), whereas in 
California (Shaw et al. 2003) and Sweden 
(Cedergren et al. 2002), cases were diag-
nosed up to 1 year after birth. However, we 
anticipate that random under  reporting would 
weaken any observed association rather than 
introduce a spurious effect. A further discrep-
ancy between studies was whether the study 
population had been extended beyond live 
births. In the European Union, terminations 
accounted for 18% and fetal deaths for 2% of 
congenital anomalies [European Surveillance 
of Congenital Anomalies (EUROCAT) 
2005]. However, whereas some study popu-
lations included terminations and stillbirths 
(i.e., Dodds et al. 1999; Klotz and Pyrch 1999; 
Nieuwenhuijsen et al. 2008), others did not 
(i.e., Cedergren et al. 2002; Chisholm et al. 
2008; Hwang et al. 2008).
The strongest, albeit relatively modest, evi-
dence for a possible association with DBPs was 
found for one specific type of cardiac defect: 
ventricular septal defect. This finding is of inter-
est in light of studies of other environ  mental 
exposures in which associations for this par-
ticular birth defect have been observed with, for 
example, air pollutants (Gilboa et al. 2005; Ritz 
et al. 2002). However, ventricular septal defects 
are also among the anomalies that are most 
subject to variable diagnosis and reporting in 
routine anomaly registries; all three studies that 
reported increased risks of ventricular septal 
defects in relation to high chlorination exposure 
were based on large, regional or nationwide, 
congenital anomaly registries in which vari-
able reporting is common (Rankin et al. 2005) 
and may affect geographic comparison studies 
such as the DBP studies.
Only one study (Shaw et al. 2003) has 
examined gene–environment interaction 
and/or the presence of susceptible groups, 
and this study did not find any effect. There 
is some evidence, however, to suggest that 
cytochrome P450 2E1 (CYP2E1) or gluta-
thione S-transferase T1 may play a role in 
the susceptibility to DBPs, and this should 
be further explored (Infante-Rivard 2004; 
Infante-Rivard et al. 2002). 
Animal and cell studies have found some 
effects associated with DBPs. NTDs and 
cranio  facial defects have been found with 
administration of di/trichloro  acetic acid in 
rats (Smith et al. 1989a), and cardiac mal-
formations have been induced at high doses of 
dichloro  acetic acid (Smith et al. 1992). Hunter 
et al. (1996) observed changes in neural tube 
develop  ment when mouse embryos were 
exposed to HAAs. Several chloro  acetonitrile 
compounds have been shown to increase the 
rate of resorption, to reduce fetal body weight 
and survival (Smith et al. 1997), and to result 
in an increase in malformations of the cardio-
vascular, digestive, soft tissue, and uro  genital 
systems (Smith et al. 1988, 1989b). However, 
these adverse develop  mental effects have only 
been demonstrated at high doses in conjunc-
tion with severe feto  toxicity. Furthermore, the 
mechanisms for possible effects are still unclear, 
although some have been suggested. Low levels 
of folate have been associated with several con-
genital anomalies such as neural tube defects 
(EUROCAT 2003). Alston (1991) found that 
chloroform inhibited methionine bio  synthesis 
in cell culture. Dow and Green (2000) showed 
that trichloro  acetic acid interacts with vita-
min B12, probably by a free radical mecha-
nism, inhibiting both the methyl  malonyl 
coenzyme A and methio  nine salvage pathways 
in rats. As a result of the latter, a secondary 
folate deficiency develops because of the methyl 
folate trap, leading to a major impairment in 
formate metabolism. Folate and folic acid are 
forms of vitamin B that are involved in the syn-
thesis, repair, and functioning of DNA and are 
required for the production and maintenance 
of cells (Kamen 1997). Folate plays an impor-
tant role for cells under  going rapid turnover, 
such as tissues in the developing fetus.
The Way Forward
Given the many studies conducted and the 
limited evidence of an association between 
chlorination by-products and congenital 
anomalies, we might ask whether there is a 
need to conduct more studies, and if so, what 
should they look at? Disinfection of drinking 
water is an important part of public health, 
and many people are exposed to chlorination 
by-products not only through ingestion but 
also through other activities such as shower-
ing and bathing. Ongoing surveillance of any 
possible adverse health effects is therefore war-
ranted, even though the relative risks may be 
small. As mentioned above, the mixture of the 
by-products may differ by geographic area and 
time, for example, because of changes in water 
treatment methods, and generally only indica-
tor substances such as TTHM have been used 
to examine the health risks. It is important 
that we understand the under  lying mixture 
of the by-products, both in existing and new 
studies, and where possible, we should exam-
ine any possible health risks of specific DBPs 
or mixtures. Studies are needed to exam-
ine the potential effects of certain mixtures, 
such as brominated species, in more specific 
locations. For example, Perth, Australia (see 
Chisholm et al. 2008) or the Barcelona area 
in Spain (see Villanueva et al. 2006) might be 
suitable places because of their high levels of 
brominated compounds. 
Furthermore, it would be worthwhile to 
examine the various exposure pathways and 
routes other than ingestion in more detail, 
specifically for volatile by-products such as 
THMs, as the level of exposure and metabo-
lism may be different and the meas  ures for 
exposure prevention are likely to be differ-
ent. This can probably only be done in case–
control studies; in such studies it would be 
necessary to estimate exposure in the most 
critical (early) periods of pregnancy, which 
could prove difficult. Prospective exposure 
assessment through a cohort design would be 
more appropriate, but practical and financial 
constraints preclude such a study, as the size 
of the cohort would need to be extremely 
large to study rare congenital anomalies.
Regarding the outcomes, the focus of future 
studies should be on subcategories of congenital 
anomalies, rather than on the whole group, and Chlorination and congenital anomalies
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should focus on anomalies for which the ascer-
tainment is reasonably complete and consistent 
if registry-based designs are used. Findings for 
ventricular septal defects should be followed 
up, preferably in well-designed case–control 
studies. The study by Nieuwenhuijsen et al. 
(2008) showed an excess risk for bromo  form 
and gastro  schisis; these findings may be worth 
examining in more detail and in a different 
population. One of the problems in that study 
was the low levels of bromo  form in England 
and Wales, and future studies should be con-
ducted in places where bromo  form levels are 
higher (such as Perth).
Further work is needed on the relation 
between potential confounders such as smoking 
and alcohol intake, as well as the relation with 
by-products in the water and personal behav-
ioral characteristics such as tap water ingestion 
(instead of bottled water), showering, and bath-
ing to examine to what extent confounding 
may explain findings for registry-based studies 
where this information is missing. 
There is some suggestion that some chlo-
rination by-products may interfere with folate 
metabolism; this and other potential mecha-
nisms such as oxidative stress and geno  toxicity 
could be examined with biomarkers in preg-
nant women to assess to what extent this may 
be possible. Furthermore, geno  typing may 
identify susceptible populations (e.g., those 
with CYP2E1). 
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